Technical Analysis for RPTX - Repare Therapeutics Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | N/A | Up | Down |
Historical RPTX trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Down 3% | about 21 hours ago | |
Down 2 % | about 21 hours ago | |
Down 1% | about 21 hours ago | |
Fell Below 20 DMA | about 21 hours ago | |
20 DMA Support | 2 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Repare Therapeutics is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Genetics Precision Medicine Genome Cancer Therapies CRISPR Synthetic Lethality
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Genetics Precision Medicine Genome Cancer Therapies CRISPR Synthetic Lethality
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 46.44 |
52 Week Low | 21.45 |
Average Volume | 137,552 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 34.81 |
20-Day Moving Average | 38.36 |
10-Day Moving Average | 41.11 |
Average True Range | 3.06 |
ADX | 37.13 |
+DI | 21.43 |
-DI | 18.45 |
Chandelier Exit (Long, 3 ATRs ) | 37.25 |
Chandelier Exit (Short, 3 ATRs ) | 40.96 |
Upper Bollinger Band | 45.97 |
Lower Bollinger Band | 30.75 |
Percent B (%b) | 0.46 |
BandWidth | 39.68 |
MACD Line | 1.60 |
MACD Signal Line | 2.00 |
MACD Histogram | -0.4077 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 39.67 | ||||
Resistance 3 (R3) | 39.72 | 39.11 | 39.34 | ||
Resistance 2 (R2) | 39.11 | 38.61 | 39.09 | 39.23 | |
Resistance 1 (R1) | 38.41 | 38.30 | 38.11 | 38.36 | 39.12 |
Pivot Point | 37.80 | 37.80 | 37.65 | 37.78 | 37.80 |
Support 1 (S1) | 37.10 | 37.30 | 36.80 | 37.05 | 36.28 |
Support 2 (S2) | 36.49 | 36.99 | 36.47 | 36.17 | |
Support 3 (S3) | 35.79 | 36.49 | 36.06 | ||
Support 4 (S4) | 35.74 |